Juan Andino, MD, highlights SUO session on telehealth in urology

In this video, Juan J. Andino, MD, MBA, outlines key points from the session, “Telehealth and Cancer: Public Policy and Future Directions,” which he delivered at the Society of Urologic Oncology 25th Annual Meeting in Dallas, Texas. Andino is an assistant professor of urology at the University of California, Los Angeles.

Video Transcript:

Many of the things that we're going to be talking about this afternoon, but for the listeners, is highlighting some of the work force shortage issues that we know exist in urology more broadly. And obviously, if we narrow that down to the oncology world, they're probably even larger than we realize and that we have data to demonstrate. [There’s] a lot of ongoing public policy work that the AUA is doing, but things are just so unknown. Like we were just chatting about, Hannah, right now, there's been an extension of the telehealth flexibilities because of the pandemic, but it's set to expire in the next couple of weeks, December 31. Without Congressional action, all the progress that has been made—the new normal, so to speak—that patients, physicians, and providers alike have become used to is at risk of potentially going back to pre-pandemic, 2019 levels, which in my opinion, would be a little bit disastrous in terms of access to care. Those are going to be some of the key talking points for this session this afternoon is the access to care at a broader level for specialty care, and how telehealth can be used to try to mitigate that and help remove some of the barriers to accessing specialty and oncologic care.

This transcript was AI generated and edited by human editors for clarity.